Fig. 4. Linc01133 functions as a ceRNA of miR-145-5p.
miR-145-5p counteracted with linc01133 in the proliferation and cell cycle progression of gastric cnacer cells demonstrated by EdU (A, B), FASC (C) and MTS assay (D). Linc01133 with miR-145-5p binding sites mutation failed to accelerate the tumor cell growth demonstrated by EdU (E, F) and MTS (G). Each experiment was performed in triplicates. Data are shown as mean ± SD, *P < 0.05, **P < 0.01, N.S no significance.